Advertisement

Topics

Atossa Genetics, Inc. Company Profile

15:55 EDT 24th September 2018 | BioPortfolio

Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, is based in Seattle, WA, and is focused on preventing breast cancer through the commercialization of patented, FDA-cleared diagnostic medical devices and patented, laboratory developed tests (LDT) that can detect precursors to breast cancer up to eight years before mammography, and through research and development that will permit it to commercialize treatments for pre-cancerous lesions.


News Articles [381 Associated News Articles listed on BioPortfolio]

Atossa Genetics (ATOS) - Atossa raises $13.4m in rights offering

Edison Investment Research - Pharmaceutical & healthcare - Atossa Genetics: Atossa’s previously announced rights offering closed on 30 May 2018, generating $13.3m in gross proceeds ($12.1m net) ...

Atossa Genetics (ATOS) - Endoxifen to start Phase II studies shortly

Edison Investment Research - Pharmaceutical & healthcare - Atossa Genetics: Atossa Genetics is preparing to start Phase II studies of both its oral and topical endoxifen formulations in Q218. Endoxife...

Atossa Genetics Inc Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 17022018] Prices from USD $350

Atossa Genetics Inc Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Atossa Genetics Inc Mergers Acquisitions MA, Partnerships Alliances and Investments re...

Atossa Genetics Inc Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 23042018] Prices from USD $350

Atossa Genetics Inc Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Atossa Genetics Inc Mergers Acquisitions MA, Partnerships Alliances and Investments re...

Atossa Genetics' (ATOS) Corporate Conference Call Transcript

Atossa Genetics (ATOS) CEO Steve Quay on Preliminary Results from Male Phase 1 Study of Topical Endoxifen Conference (Transcript)

Pre-Market Technical Scan on Healthcare Equities -- Atossa Genetics, Palatin Technologies, ...

WallStEquities.com strives to bring the best free research to the investment community.  Today we are offering reports on ATOS, PTN, QTNT, and AVDL which can Read more...

Your Daily Pharma Scoop: Advaxis Trial Cleared, Atossa Trial Proceeds, Amgen Resubmits NDA

Drugs and Medications [0 Results]

None

Clinical Trials [324 Associated Clinical Trials listed on BioPortfolio]

Genetics Education: Preparing Physicians for the Future

This study examines the best way to teach genetics to family medicine residents. First year family medicine residents at the University of Toronto will be taught basic clinical genetics as...

Experiences of Genetics Patients With Visible Abnormalities Who Facilitate Teaching in Genetics Clinics

This study will describe the experience of patients with visible physical abnormalities in the genetics clinic when they are involved in teaching others about their condition. Information ...

Virtual Reality Intervention in Cancer Genetics

The goal of this study is to evaluate a virtual reality-based intervention for training health care providers who are not genetics specialists to effectively communicate with and counsel p...

Genetics Tests : How to Improve Management Within Two Medical Specialities

This survey will assess discrepancies between official clinical genetics guidelines and practices within 3 West regions of France.

Genetics of Asthma and Bronchial Hyperresponsiveness

To investigate the genetics of asthma by reexamining a carefully characterized population of patients with asthma, and by studying their families.

Companies [35 Associated Companies listed on BioPortfolio]

Atossa Genetics, Inc.

Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, is based in Seattle, WA, and is focused on preventing breast cancer through the commercialization of patente...

AccessDNA, Inc.

AccessDNA is the leading online consumer resource for genetics. The company combines high-quality content about genetics with access to, and evaluation of, relevant testing, couns...

Ambry Genetics Corporation

Ambry Genetics is a privately held healthcare company with the industry’s most comprehensive suite of genetic testing solutions, benefiting 90% of all U.S. patients covered b...

Interleukin Genetics, Inc.

Interleukin Genetics, Inc. (OTCQB: ILIU) develops and markets a line of genetic tests under the Inherent Health® brand. The products empower individuals to prevent ce...

Population Genetics

Harnessing The Power of Populations™ Population Genetics’ approach takes the process of genetic analysis one step further. It enables the elaboration and testing of distinct hypotheses...

More Information about "Atossa Genetics, Inc." on BioPortfolio

We have published hundreds of Atossa Genetics, Inc. news stories on BioPortfolio along with dozens of Atossa Genetics, Inc. Clinical Trials and PubMed Articles about Atossa Genetics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Atossa Genetics, Inc. Companies in our database. You can also find out about relevant Atossa Genetics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Breast Cancer
Track and monitor developments in breast cancer research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record